A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 7804-7817

  Schaefer, Malinda R ^a   Williams, Maya ^b   Kulpa, Deanna A ^c   Blakely, Pennelope K ^c   Yaffee, Anna Q ^d   Collins, Kathleen L ^a,b,c,d  

^a Graduate Program Immunology

^b Graduate Program in Cellular and Molecular Biology

^c Department of Medicine ^*

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; HLA C ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL TRANSPORT; IMMUNOSURVEILLANCE; INTERNALIZATION; MACROPHAGE FUNCTION; PHOSPHORYLATION; PRIORITY JOURNAL; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CELL STRAIN U937; CROSS PRESENTATION; CYTOLOGY; CYTOPLASM; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LYSOSOME; MACROPHAGE; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MEMBRANE; CROSS-PRIMING; CYTOPLASM; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; GENE EXPRESSION REGULATION; HLA-C ANTIGENS; HUMANS; LYSOSOMES; MACROPHAGES; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 50949116894     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.7804     Document Type: Article

References (41)

1. Sigal, L. J., S. Crotty, R. Andino, and K. L. Rock. 1999. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398: 77-80.
2. + T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73: 1-77.
3. Berke, G. 1995. The CTL's kiss of death. Cell 81: 9-12.
4. Parham, P. 2005. Influence of KIR diversity on human immunity. Adv. Exp. Med. Biol. 560: 47-50.
5. + T cells. J. Immunol. 173: 7223-7229.
6. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90: 12000-12004.
7. McCutcheon, J. A., J. Gumperz, K. D. Smith, C. T. Lutz, and P. Parham. 1995. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181: 2085-2095.
8. Neefjes, J. J., and H. L. Ploegh. 1988. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with β2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol. 18: 801-810.
9. Selini, A., A. Beretta, C. De Santis, R. Meneveri, A. Martayan, M. C. Mazzilli, E. Appella, A. G. Siccardi, P. G. Natali, and P. Giacomini. 1996. Distinctive features of the α1-domain α helix of HLA-C heavy chains free of β2-microglobulin. Hum. Immunol. 46: 69-81.
10. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142: 3320-3328.
11. Kozlowska, A., W. Gorczyca, Z. Mackiewicz, I. Wojciechowska, and P. Kusnierczyk. 2000. Octapeptide but not nonapeptide from HIV-1 p24gag protein upregulates cell surface HLA-C expression. HIV Med. 1: 200-204.
12. Roeth, J. F., M. Williams, M. R. Kasper, T. M. Filzen, and K. L. Collins. 2004. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cyto-plasmic tail. J. Cell Biol. 167: 903-913.
13. Fleis, R., T. Filzen, and K. L. Collins. 2002. Species-specific effects of HIV-1 Nef-mediated MHC-I downmodulation. Virology 303: 120-129.
14. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11: 281-288.
15. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90: 8392-8396.
16. Bonaparte, M. I., and E. Barker. 2004. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I Molecules. Blood 104: 2087-2094.
17. Giacomini, P., A. Beretta, M. R. Nicotra, G. Ciccarelli, A. Martayan, C. Cerboni, L. Lopalco, D. Bini, L. Delfino, G. B. Ferrara, et al. 1997. HLA-C heavy chains free of β2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-γ responsiveness. Tissue Antigens 50: 555-566.
18. Swann, S. A., M. Williams, C. M. Story, K. R. Bobbitt, R. Fleis, and K. L. Collins. 2001. HIV-1 Nef blocks transport of MHC class I Molecules to the cell surface via a PI 3-kinase-dependent pathway. Virology 282: 267-277.
19. Parham, P., and F. M. Brodsky. 1981. Partial purification and some properties of BB7.2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3: 277-299.
20. Kasper, M. R., and K. L. Collins. 2003. Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J. Virol. 77: 3041-3049.
21. Le Gall, S., F. Buseyne, A. Trocha, B. D. Walker, J. M. Heard, and O. Schwartz. 2000. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J. Virol. 74: 9256-9266.
22. Caplan, S., N. Naslavsky, L. M. Hartnell, R. Lodge, R. S. Polishchuk, J. G. Donaldson, and J. S. Bonifacino. 2002. A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I Molecules to the plasma membrane. EMBO J. 21: 2557-2567.
23. Aiken, C., J. Konner, N. Landau, M. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76: 853-864.
24. Schwartz, O., A. Dautry-Varsat, B. Goud, V. Marechal, A. Subtil, J. M. Heard, and O. Danos. 1995. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69: 528-533.
25. Benevolo, M., M. Mottolese, G. Piperno, I. Spcrduti, A. Cione, L. Sibilio, A. Martayan, R. P. Donnorso, M. Cosimelli, and P. Giacomini. 2007. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant. Am. J. Surg. Pathol. 31: 76-84.
26. Thammavongsa, V., G. Raghuraman, T. M. Filzen, K. L. Collins, and M. Raghavan. 2006. HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J. Immunol. 177:3150-3161.
27. Moore, C. A., S. K. Milano, and J. L. Benovic. 2007. Regulation of receptor trafficking by GRKs and arrestins. Annu. Rev. Physiol. 69: 451-482.
28. Wolfe, B. L., and J. Trejo. 2007. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic 8: 462-470.
29. Neisig, A., C. J. Melief, and J. Neefjes. 1998. Reduced cell surface expression of HLA-C Molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160: 171-179.
30. Bonifacino, J. S. 2004. The GGA proteins: adaptors on the move. Nat. Rev. Mol. Cell Biol. 5: 23-32.
31. Rosenberg, Z. F., and A. S. Fauci. 1991. Immunopathogenesis of HIV infection. FASEB J. 5: 2382-2390.
32. Billard, E., C. Cazevieille, J. Domand, and A. Gross. 2005. High susceptibility of human dendritic cells to invasion by the intraccllular pathogens Brucella suis, B. abortus, and B. melitensis. Infect. Immun. 73: 8418-8424.
33. Fontes, P., M. T. Alvarez-Martinez, A. Gross, C. Camaud, S. Kohler, and J. P. Liautard. 2005. Absence of evidence for the participation of the macrophage cellular prion protein in infection with Brucella suis. Infect. Immun. 73: 6229-6236.
34. Jimenez de Bagues, M. P., S. Dudal, J. Dornand, and A. Gross. 2005. Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin. Immunol. 114: 227-238.
35. Kraus, M. D., B. Amatya, and Y. Kimula. 1999. Histopathology of typhoid enteritis: morphologic and immunophenotypic findings. Mod. Pathol. 12: 949-955.
36. Peters, N., and D. Sacks. 2006. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol. Rev. 213: 159-179.
37. Bodnar, K. A., N. V. Serbina, and J. L. Flynn. 2001. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69: 800-809.
38. Chen, J., M. Reyes, M. Clarke, and II. A. Shuman. 2007. Host cell-dependent secretion and translocation of the LepA and LepB effectors of Legionella pneu-mophila. Cell. Microbiol: 1660-1671.
39. Kasper, M. R., J. F. Roeth, M. Williams, T. M. Filzen, R. I. Fleis, and K. L. Collins. 2005. HIV-1 Nef disrupts antigen presentation early in the secretory pathway. J. Biol. Chem. 280: 12840-12848.
40. Williams, M., J. F. Rocth, M. R. Kasper, T. Filzen, and K. L. Collins. 2005. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for co-precipitation of Nef with HLA-A2. J. Virol. 79: 632-636.
41. Wonderlich, E. R., M. Williams, and K. L. Collins. 2008. The tyrosine binding pocket in the adaptor protein 1 (AP-1) {micro} 1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J. Biol. Chem. 283: 3011-3022.